Additional Information
Book Details
Abstract
Get a quick, expert overview of alopecia with this concise, practical resource. Dr. Mariya Miteva covers high-interest clinical topics including hair cosmeceuticals, new medications in clinical trials, off-label treatment technologies, and much more. It’s an ideal resource for dermatologists, dermatopathologists, students, fellows, and researchers interested in hair loss.
- Presents rich visual information combined with expert opinions from the most renowned hair experts practicing today.
- Covers basic knowledge on healthy hair, hair pathology, and hair and scalp dermatoscopy (trichoscopy).
- Contains focused yet complete coverage of non-scarring alopecia, primary lymphocytic cicatricial alopecia, primary neutrophilic ciatricial alopecia, hair loss management, and miscellaneous hair disorders such as hair loss in children, hair and scalp infections, hair changes due to drugs, and more.
- Consolidates today’s available information and experience in this important area into one convenient resource.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Alopecia | i | ||
| Alopecia | iii | ||
| Copyright | iv | ||
| List of Contributors | v | ||
| Preface | ix | ||
| Contents | xi | ||
| 1 - Healthy Hair (Anatomy, Biology, Morphogenesis, Cycling, and Function) | 1 | ||
| INTRODUCTION | 1 | ||
| EMBRYOLOGY | 1 | ||
| Stages of Hair Follicle Formation | 1 | ||
| Molecular and Genetic Basis of Hair Follicle Embryogenesis | 3 | ||
| ANATOMY AND CYTOLOGY OF THE PILOSEBACEOUS UNIT | 3 | ||
| Immunologic Components of the Hair Follicle | 5 | ||
| Other Constituents of the Pilosebaceous Unit | 6 | ||
| TYPES OF HAIR FOLLICLES | 7 | ||
| HAIR FOLLICLE CYCLING | 7 | ||
| Anagen Stage | 9 | ||
| Phases of anagen stage | 9 | ||
| Regulatory pathways/molecules | 9 | ||
| Hair follicle stem cells are key protagonists during anagen development | 9 | ||
| Catagen Stage | 10 | ||
| Phases of catagen stage | 10 | ||
| Regulatory pathways/molecules | 10 | ||
| Telogen Stage | 11 | ||
| Regulating pathways/molecules | 11 | ||
| Exogen | 12 | ||
| Kenogen | 12 | ||
| Differences of Hair Follicle Cycling in Various Anatomic Locations | 12 | ||
| Hair Follicle Metabolism During Cycling and Role of Oxidative Damage | 13 | ||
| HAIR SHAPE AND HAIR SHAFT COMPOSITION | 13 | ||
| MELANOGENESIS IN THE HAIR FOLLICLE | 13 | ||
| NORMAL HUMAN SCALP CHARACTERISTICS IN DIFFERENT RACES | 13 | ||
| HUMAN SCALP IN DIFFERENT AGES | 14 | ||
| DIFFERENCES BETWEEN HUMANS AND MOUSE HAIR FOLLICLES MORPHOLOGY AND CYCLING | 15 | ||
| NEUROENDOCRINOLOGY OF THE HAIR FOLLICLE | 15 | ||
| CONCLUSIONS | 16 | ||
| REFERENCES | 16 | ||
| 2 - Hair Pathology: The Basics | 23 | ||
| SCALP BIOPSY | 23 | ||
| HORIZONTAL (TRANSVERSE) SECTIONS | 23 | ||
| HAIR FOLLICLES AND HAIR COUNTS: THE BASICS | 23 | ||
| LEVELS ALONG THE FOLLICULAR LENGTH | 24 | ||
| FOLLICULAR COUNTS | 24 | ||
| NONSCARRING ALOPECIA | 24 | ||
| Alopecia Areata | 24 | ||
| Alopecia Areata Incognito | 28 | ||
| Chronic Telogen Effluvium | 29 | ||
| Androgenetic Alopecia | 29 | ||
| Trichotillomania | 29 | ||
| SCARRING ALOPECIA | 29 | ||
| Discoid Lupus Erythematosus | 30 | ||
| Lichen Planopilaris and Frontal Fibrosing Alopecia | 31 | ||
| Central Centrifugal Cicatricial Alopecia | 33 | ||
| Traction Alopecia | 33 | ||
| Folliculitis Decalvans | 33 | ||
| Dissecting Cellulitis of the Scalp | 35 | ||
| Acne Keloidalis Nuchae | 36 | ||
| Erosive Pustular Dermatosis of the Scalp | 36 | ||
| MISCELLANEOUS | 36 | ||
| Seborrheic Dermatitis | 36 | ||
| Scalp Psoriasis | 37 | ||
| Lichen Simplex Chronicus | 37 | ||
| Tinea Capitis | 38 | ||
| Syphilitic Alopecia | 38 | ||
| Permanent Alopecia After Chemotherapy | 39 | ||
| REFERENCES | 40 | ||
| 3 - Hair and Scalp Dermatoscopy (Trichoscopy) | 43 | ||
| INTRODUCTION | 43 | ||
| HOW TRICHOSCOPY HELPS THE CLINICIAN | 43 | ||
| TRICHOSCOPY DEVICES AND THEIR PARTICULARITIES | 43 | ||
| HOW TO EVALUATE THE PATIENT | 44 | ||
| TRICHOSCOPIC SIGNS AND PATTERNS | 46 | ||
| Follicular Signs | 46 | ||
| Yellow dots | 46 | ||
| Keratotic plugs | 46 | ||
| Black dots | 47 | ||
| Red dots | 47 | ||
| White dots | 47 | ||
| Loss of follicular openings | 48 | ||
| Perifollicular erythema | 48 | ||
| Scaling (perifollicular/interfollicular) | 48 | ||
| Hyperpigmenation | 48 | ||
| White-gray halo | 49 | ||
| Vascular Patterns | 49 | ||
| Hair Shafts | 51 | ||
| Hair shaft diameter variability | 51 | ||
| Short regrowing hairs | 51 | ||
| Broken hairs | 52 | ||
| Exclamation mark hairs and coudability hairs | 53 | ||
| Comma hairs and corkscrew hairs | 54 | ||
| Hair shafts in congenital syndromes | 54 | ||
| REFERENCES | 56 | ||
| 4 - Alopecia Areata and Alopecia Areata Incognita | 59 | ||
| INTRODUCTION | 59 | ||
| ETIOPATHOGENESIS | 59 | ||
| CLINICAL FEATURES | 59 | ||
| DIAGNOSIS | 61 | ||
| DIFFERENTIAL DIAGNOSIS | 62 | ||
| ASSOCIATED DISEASES | 63 | ||
| TREATMENT | 63 | ||
| REFERENCES | 65 | ||
| 5 - Androgenetic Alopecia | 67 | ||
| INTRODUCTION | 67 | ||
| CLINICAL AND HISTOLOGIC PRESENTATION | 67 | ||
| EPIDEMIOLOGY | 69 | ||
| ETIOLOGY AND PATHOGENESIS | 69 | ||
| MANAGEMENT: DIAGNOSIS AND DIFFERENTIAL | 70 | ||
| MANAGEMENT: PREVENTION, TREATMENT, MECHANISMS OF ACTION, AND PROGNOSIS | 72 | ||
| RESEARCH RELATED TO AGA PATHOGENESIS, MECHANISMS OF DISEASE, AND PROPOSED AREAS OF TREATMENT | 74 | ||
| Genetic/Genomic Targets | 74 | ||
| Signaling Targets | 75 | ||
| Cell Therapy | 76 | ||
| Animal Models of Human Androgenetic Alopecia | 77 | ||
| CONCLUSIONS | 77 | ||
| REFERENCES | 77 | ||
| 6 - Telogen Effluvium | 83 | ||
| INTRODUCTION | 83 | ||
| EPIDEMIOLOGY | 83 | ||
| PATHOGENESIS | 83 | ||
| Physiology of Hair Shedding | 83 | ||
| Pathophysiology of Telogen Effluvium | 84 | ||
| Inciting Factors | 84 | ||
| CLINICAL FEATURES | 85 | ||
| Acute Telogen Effluvium | 85 | ||
| Chronic Telogen Effluvium | 85 | ||
| HISTOPATHOLOGY | 86 | ||
| DIAGNOSIS | 88 | ||
| History | 88 | ||
| Physical Examination | 88 | ||
| Hair Pull Test | 89 | ||
| Dermoscopy | 89 | ||
| Wood’s Lamp Examination | 89 | ||
| Investigations | 89 | ||
| DIFFERENTIAL DIAGNOSES | 89 | ||
| MANAGEMENT | 89 | ||
| Removal of the Inciting Factor | 90 | ||
| Cosmetic Treatments | 90 | ||
| Psychologic Support | 90 | ||
| Topical Minoxidil | 91 | ||
| Nutritional Supplementation | 91 | ||
| Emerging Treatments | 91 | ||
| PROGNOSIS | 91 | ||
| REFERENCES | 91 | ||
| 7 - Trichotillomania | 95 | ||
| INTRODUCTION | 95 | ||
| Definition | 95 | ||
| General Concepts | 95 | ||
| ETIOLOGY | 95 | ||
| Trichoteiromania | 96 | ||
| Trichotemnomania | 96 | ||
| Trichodaganomania | 96 | ||
| Trichophagia and Trichobezoar | 96 | ||
| CLINICAL PRESENTATION | 96 | ||
| TRICHOSCOPY | 97 | ||
| PATHOLOGY | 99 | ||
| DIFFERENTIAL DIAGNOSIS | 99 | ||
| MANAGEMENT | 101 | ||
| REFERENCES | 101 | ||
| 8 - Frontal Fibrosing Alopecia | 103 | ||
| INTRODUCTION | 103 | ||
| EPIDEMIOLOGY | 103 | ||
| PATHOGENESIS | 103 | ||
| Autoimmune Etiology | 103 | ||
| Hormonal Etiology | 103 | ||
| Lipid Metabolism Dysfunction | 104 | ||
| Neurogenic Inflammation | 104 | ||
| Genetics | 104 | ||
| Environmental Factors | 104 | ||
| CLINICAL FEATURES | 104 | ||
| DIAGNOSIS | 108 | ||
| TREATMENT | 108 | ||
| FOLLOW-UP | 110 | ||
| REFERENCES | 111 | ||
| 9 - Fibrosing Alopecia in a Pattern Distribution | 115 | ||
| PATTERNED HAIR LOSS | 115 | ||
| CICATRICIAL PATTERN HAIR LOSS | 115 | ||
| CONCLUSION | 120 | ||
| REFERENCES | 124 | ||
| 10 - Central Centrifugal Cicatricial Alopecia | 127 | ||
| INTRODUCTION | 127 | ||
| HAIR MORPHOLOGY AND PRACTICES AMONGST AFRICAN PATIENTS | 127 | ||
| HISTORY AND TERMINOLOGY | 127 | ||
| EPIDEMIOLOGY | 128 | ||
| ETIOPATHOGENESIS | 128 | ||
| CLINICAL PRESENTATION | 128 | ||
| DERMOSCOPY | 129 | ||
| HISTOLOGY | 130 | ||
| DIFFERENTIAL DIAGNOSIS | 131 | ||
| MANAGEMENT | 131 | ||
| GENERAL MEASURES | 131 | ||
| MEDICAL TREATMENT | 131 | ||
| SURGICAL TREATMENT | 132 | ||
| CONCLUSION | 132 | ||
| REFERENCES | 132 | ||
| 11 - Traction Alopecia | 135 | ||
| INTRODUCTION | 135 | ||
| DEMOGRAPHIC FACTORS | 135 | ||
| CLINICAL PRESENTATION | 135 | ||
| DIFFERENTIAL DIAGNOSIS | 138 | ||
| DIAGNOSTIC WORKUP | 139 | ||
| Trichoscopy | 139 | ||
| Histology | 139 | ||
| TREATMENT, EDUCATION, AND PROGNOSIS | 140 | ||
| REFERENCES | 141 | ||
| 12 - Lichen Planopilaris | 143 | ||
| INTRODUCTION | 143 | ||
| EPIDEMIOLOGY | 143 | ||
| ETIOLOGY | 143 | ||
| PATHOGENESIS | 143 | ||
| CLINICAL FEATURES | 144 | ||
| DERMOSCOPY | 145 | ||
| HISTOPATHOLOGY | 145 | ||
| MANAGEMENT | 146 | ||
| Topical/Intralesional Therapies | 146 | ||
| Systemic Therapies | 147 | ||
| CONCLUSION | 148 | ||
| REFERENCES | 148 | ||
| 13 - Discoid Lupus Erythematosus | 151 | ||
| INTRODUCTION | 151 | ||
| EPIDEMIOLOGY | 151 | ||
| ETIOLOGY AND PATHOGENESIS | 151 | ||
| CLINICAL FINDINGS | 152 | ||
| DERMATOSCOPIC FINDINGS | 153 | ||
| HISTOPATHOLOGIC FINDINGS | 154 | ||
| PATIENT MANAGEMENT | 155 | ||
| First-Line Therapy | 156 | ||
| Topical/intralesional steroids and calcineurin inhibitors | 156 | ||
| Antimalarials | 156 | ||
| Second-Line Therapy | 156 | ||
| Biologic agents | 157 | ||
| CONCLUSION | 157 | ||
| REFERENCES | 157 | ||
| 14 - Folliculitis Decalvans | 161 | ||
| HISTORY AND DEFINITION | 161 | ||
| History | 161 | ||
| Definition | 161 | ||
| EPIDEMIOLOGY | 161 | ||
| ETIOPATHOGENESIS | 161 | ||
| CLINICAL PRESENTATION: SIGNS AND SYMPTOMS | 161 | ||
| TRICHOSCOPY | 162 | ||
| HISTOPATHOLOGY | 162 | ||
| DIAGNOSIS | 162 | ||
| Clinical History | 162 | ||
| Dermatologic Examination | 162 | ||
| Photography | 163 | ||
| Bacterial Cultures | 163 | ||
| Skin Biopsy | 163 | ||
| DIFFERENTIAL DIAGNOSIS | 163 | ||
| TREATMENTS | 164 | ||
| Oral Treatment (Table 14.1) | 164 | ||
| PROGNOSIS | 165 | ||
| REFERENCES | 165 | ||
| 15 - Dissecting Cellulitis of the Scalp | 167 | ||
| DEFINITION | 167 | ||
| EPIDEMIOLOGY | 167 | ||
| ETIOLOGY | 167 | ||
| CLINICAL FEATURES | 167 | ||
| TRICHOSCOPY | 167 | ||
| PATHOLOGY | 168 | ||
| ASSOCIATED CONDITIONS | 169 | ||
| DIFFERENTIAL DIAGNOSIS | 169 | ||
| TREATMENT | 169 | ||
| Corticosteroids | 170 | ||
| Oral Antibiotics | 170 | ||
| Oral Retinoids | 170 | ||
| Other Treatments | 170 | ||
| PROGNOSIS | 170 | ||
| REFERENCES | 170 | ||
| 16 - Acne Keloidalis Nuchae | 173 | ||
| INTRODUCTION | 173 | ||
| EPIDEMIOLOGY | 173 | ||
| PATHOGENESIS | 173 | ||
| CLINICAL FINDINGS | 173 | ||
| TRICHOSCOPY | 174 | ||
| PATHOLOGY | 174 | ||
| DIFFERENTIAL DIAGNOSIS | 174 | ||
| TREATMENT | 175 | ||
| PROGNOSIS | 176 | ||
| REFERENCES | 176 | ||
| 17 - Erosive Pustular Dermatosis of the Scalp | 179 | ||
| INTRODUCTION | 179 | ||
| EPIDEMIOLOGY | 179 | ||
| PATHOGENESIS | 179 | ||
| CLINICAL FINDINGS | 180 | ||
| TRICHOSCOPY | 180 | ||
| PATHOLOGY | 180 | ||
| DIFFERENTIAL DIAGNOSIS | 180 | ||
| TREATMENT | 180 | ||
| PROGNOSIS | 181 | ||
| REFERENCES | 181 | ||
| 18 - Hair and Scalp Disorders Associated With Systemic Disease (Secondary Alopecia) | 183 | ||
| AMYLOIDOSIS | 183 | ||
| BULLOUS DISEASE | 185 | ||
| Pemphigus | 185 | ||
| Pemphigoid | 185 | ||
| Epidermolysis Bullosa | 185 | ||
| CONNECTIVE TISSUE DISEASE | 186 | ||
| Scleroderma | 186 | ||
| Dermatomyositis | 186 | ||
| Lupus Erythematosus | 187 | ||
| GRANULOMATOUS DERMATITIS | 187 | ||
| Sarcoidosis | 187 | ||
| Leprosy | 188 | ||
| MALIGNANCY | 188 | ||
| Lymphoproliferative Disorders | 188 | ||
| Alopecia Neoplastica | 188 | ||
| MISCELLANEOUS | 189 | ||
| Mastocytosis | 189 | ||
| Postoperative | 189 | ||
| Graft-Versus-Host Disease | 190 | ||
| REFERENCES | 190 | ||
| 19 - Hair Loss in Children | 193 | ||
| INTRODUCTION | 193 | ||
| PATCHY ALOPECIA IN CHILDHOOD | 193 | ||
| Alopecia Areata | 193 | ||
| Age | 193 | ||
| Association with comorbidities | 193 | ||
| Clinical presentation | 193 | ||
| Trichoscopy | 194 | ||
| Pathology | 194 | ||
| Management | 194 | ||
| Trichotillomania | 194 | ||
| Age | 194 | ||
| Association with comorbidities | 194 | ||
| Clinical presentation | 194 | ||
| 20 - Hair and Scalp Infections | 207 | ||
| INTRODUCTION | 207 | ||
| TINEA CAPITIS | 207 | ||
| Etiology | 207 | ||
| Clinical Presentation | 207 | ||
| Dermoscopy | 207 | ||
| Pathology | 208 | ||
| Culture | 209 | ||
| Management | 209 | ||
| PEDICULOSIS CAPITIS | 209 | ||
| Etiology | 209 | ||
| Clinical Presentation | 209 | ||
| Dermoscopy | 210 | ||
| Pathology | 210 | ||
| Treatment | 210 | ||
| PIEDRA | 211 | ||
| Etiology | 211 | ||
| Clinical Presentation | 211 | ||
| Dermoscopy | 213 | ||
| Culture | 213 | ||
| Treatment | 213 | ||
| SYPHILIS | 213 | ||
| Etiology | 213 | ||
| Clinical Presentation | 213 | ||
| Dermoscopy | 214 | ||
| Pathology | 214 | ||
| Treatment | 214 | ||
| DEMODEX FOLLICULITIS | 215 | ||
| 21 - The Itchy Scalp | 219 | ||
| INTRODUCTION | 219 | ||
| DERMATOLOGIC PRURITUS | 219 | ||
| PRIMARY CUTANEOUS DISEASES | 219 | ||
| Inflammatory | 219 | ||
| Seborrheic dermatitis | 219 | ||
| Scalp psoriasis | 220 | ||
| Atopic dermatitis | 222 | ||
| Dermatomyositis | 222 | ||
| Scarring alopecias | 222 | ||
| Allergic contact dermatitis | 223 | ||
| Pediculosis capitis | 223 | ||
| Neoplastic | 223 | ||
| PRURITUS WITHOUT ASSOCIATED SKIN FINDINGS | 224 | ||
| Neuropathic | 224 | ||
| Diabetes mellitus | 224 | ||
| Postherpetic neuralgia | 224 | ||
| Cervical spine disease | 224 | ||
| Treatment for neuropathic pruritus | 224 | ||
| Underlying Systemic Disease | 224 | ||
| Pruritus in the Elderly | 224 | ||
| Psychiatric Conditions | 224 | ||
| Trichotillomania | 224 | ||
| Stress and scalp itch | 225 | ||
| REFERENCES | 225 | ||
| 22 - Scalp Psoriasis | 229 | ||
| PSORIASIS OF THE SCALP AND PSORIASIFORM ALOPECIA: INTRODUCTION | 229 | ||
| CLINICAL PATTERNS | 229 | ||
| COURSE AND PROGNOSIS | 229 | ||
| What Are the Driving Forces Behind Such a Degree of Sebaceous Hypoplasia? | 230 | ||
| HISTOPATHOLOGY | 231 | ||
| TREATMENT | 231 | ||
| REFERENCES | 233 | ||
| 23 - Hair Weathering | 235 | ||
| DEFINITION | 235 | ||
| HAIR ANATOMY | 235 | ||
| CAUSES OF WEATHERING | 235 | ||
| Sunlight | 235 | ||
| Blonde and red hair | 235 | ||
| Dark hair | 235 | ||
| Gray hair | 236 | ||
| Excessive Wetting | 236 | ||
| Physical Damage | 237 | ||
| Hair extensions | 237 | ||
| Chemical Damage | 237 | ||
| Hair dye | 237 | ||
| Hair straightening | 238 | ||
| Age | 240 | ||
| DIAGNOSIS | 240 | ||
| CLINICAL EXAMINATION | 240 | ||
| Trichoptilosis | 241 | ||
| Trichoclasis | 241 | ||
| Trichoschisis | 242 | ||
| Bubble hair | 242 | ||
| TREATMENT | 242 | ||
| REFERENCES | 242 | ||
| 24 - Hair Changes due to Drugs | 245 | ||
| INTRODUCTION | 245 | ||
| Pathophysiology | 245 | ||
| HAIR AND DRUGS | 245 | ||
| Radiation Therapy | 249 | ||
| Anticoagulants | 250 | ||
| Antihypertensive Agents | 250 | ||
| Interferons | 251 | ||
| Trichoscopy | 251 | ||
| Retinol (Vitamin A) and Retinoids | 251 | ||
| Antiretrovirals | 252 | ||
| Oral Contraceptives | 252 | ||
| Drugs Acting on the Nervous System | 252 | ||
| Azathioprine | 253 | ||
| Minoxidil | 253 | ||
| Strontium Ranelate | 253 | ||
| Thallium | 254 | ||
| Cyclosporin A | 254 | ||
| Prostaglandin Analogs | 254 | ||
| Chloroquine | 254 | ||
| Permanent Alopecia due to Chemotherapy | 255 | ||
| CONCLUSIONS | 255 | ||
| REFERENCES | 256 | ||
| 25 - Novel Treatment Modalities for Hair Loss | 259 | ||
| INTRODUCTION | 259 | ||
| PLATELET-RICH PLASMA | 259 | ||
| Possible Mechanism of Action | 259 | ||
| Studies | 259 | ||
| Conclusions and Unmet Goals | 260 | ||
| LOW-LEVEL LASER/LIGHT THERAPY | 260 | ||
| Possible Mechanism of Action | 261 | ||
| Studies | 261 | ||
| Conclusions | 262 | ||
| MESOTHERAPY | 262 | ||
| Possible Mechanism of Action | 262 | ||
| Studies | 262 | ||
| Conclusions and Caveats | 262 | ||
| MICRONEEDLING | 262 | ||
| 26 - Clinical Trials and Hair Loss | 267 | ||
| BURDEN OF DISEASE IN ALOPECIA | 267 | ||
| DRUGS | 267 | ||
| Vasodilator: Minoxidil | 268 | ||
| 5α-Reductase Inhibitors: Finasteride and Dutasteride | 268 | ||
| Immunomodulators | 271 | ||
| Diuretics/Antiandrogen Therapies | 273 | ||
| Prostaglandin Agonists | 273 | ||
| DEVICES | 273 | ||
| DIETARY SUPPLEMENTS AND NUTRACEUTICALS | 273 | ||
| DRUG DEVELOPMENT AND THE FDA APPROVAL PROCESS | 274 | ||
| Preclinical Testing | 274 | ||
| Clinical Testing | 275 | ||
| Phase 1 Clinical Studies | 275 | ||
| Phase 2 Clinical Studies | 275 | ||
| Phase 3 Clinical Studies | 275 | ||
| Phase 4 Clinical Studies | 275 | ||
| Investigational New Drug | 275 | ||
| Investigational Device Exemption | 275 | ||
| New Drug Application | 276 | ||
| Clinical Study Design | 276 | ||
| ANDROGENETIC ALOPECIA: AN ILLUSTRATIVE EXAMPLE | 276 | ||
| CONCLUSIONS | 282 | ||
| REFERENCES | 282 | ||
| 27 - Hair Cosmeceuticals | 285 | ||
| SHAMPOOS | 285 | ||
| Surfactants | 285 | ||
| Anionic Surfactants | 285 | ||
| Cationic Surfactants | 286 | ||
| Amphoteric Surfactants | 286 | ||
| Nonionic Surfactants | 286 | ||
| Conditioning Shampoos | 286 | ||
| MINERAL AND VEGETABLE OILS | 287 | ||
| SHAMPOO PH AND HAIR FRIZZ | 287 | ||
| SHAMPOOS AND ALLERGY | 288 | ||
| DIFFERENT TYPES OF COSMETIC SHAMPOOS | 288 | ||
| Hair Care Guidelines for Different Hair Types | 288 | ||
| Oily hair and scalp | 288 | ||
| Dry virgin hair | 288 | ||
| Normal hair | 288 | ||
| Oily scalp and dry hair | 289 | ||
| Bleached hair | 289 | ||
| Seborrheic Dermatitis in Different Hair Types | 289 | ||
| Oily hair | 289 | ||
| Dry hair | 289 | ||
| Chemically treated hair | 289 | ||
| Natural African hair | 289 | ||
| 28 - Hair Supplements | 295 | ||
| INTRODUCTION | 295 | ||
| MICRONUTRIENTS | 295 | ||
| Vitamins | 295 | ||
| Vitamin A | 295 | ||
| Niacin (vitamin B3) | 297 | ||
| Biotin (vitamin B7) | 298 | ||
| Vitamin D | 298 | ||
| Vitamin E | 299 | ||
| Minerals | 299 | ||
| Zinc | 299 | ||
| Iron | 300 | ||
| MACRONUTRIENTS | 301 | ||
| Amino Acids and Proteins | 301 | ||
| Fatty Acids | 301 | ||
| NONVITAMIN NONMINERAL PRODUCTS | 301 | ||
| Caffeine | 301 | ||
| Melatonin | 301 | ||
| Botanical Products | 302 | ||
| MARINE COMPLEXES | 302 | ||
| CONCLUSIONS | 302 | ||
| REFERENCES | 302 | ||
| 29 - What Should the Hair Clinician Know About Hair Transplants? | 305 | ||
| OVERVIEW OF HAIR TRANSPLANTATION FOR DERMATOLOGISTS | 305 | ||
| THE PROCEDURE: EVOLUTION | 305 | ||
| FOLLICULAR UNIT TRANSPLANTATION | 306 | ||
| Strip Method Harvest | 307 | ||
| Follicular Unit Extraction Method Harvest | 307 | ||
| Recipient Site Creation and Graft Placement | 308 | ||
| Postoperative Course | 309 | ||
| SCALP REDUCTIONS, FLAPS, TISSUE EXPANDERS | 310 | ||
| ACHIEVING PATIENT SATISFACTION | 310 | ||
| PRACTICAL APPLICATIONS OF HAIR TRANSPLANTATION | 311 | ||
| Male Pattern Baldness | 311 | ||
| Female Pattern Baldness | 312 | ||
| Eyebrows and Eyelashes | 313 | ||
| Beards and Mustaches | 313 | ||
| Scar Tissue Caused by Physical Trauma | 313 | ||
| Primary Cicatricial Alopecia | 314 | ||
| Platelet-rich plasma | 315 | ||
| ACell Matristem | 315 | ||
| REFERENCES | 315 | ||
| Index | 317 | ||
| A | 317 | ||
| B | 318 | ||
| C | 318 | ||
| D | 320 | ||
| E | 320 | ||
| F | 321 | ||
| G | 322 | ||
| H | 322 | ||
| I | 324 | ||
| J | 324 | ||
| K | 324 | ||
| L | 324 | ||
| M | 325 | ||
| N | 325 | ||
| O | 326 | ||
| P | 326 | ||
| Q | 327 | ||
| R | 327 | ||
| S | 327 | ||
| T | 329 | ||
| U | 330 | ||
| V | 330 | ||
| W | 330 | ||
| Y | 331 | ||
| Z | 331 |